Study of Y-3 injection in people with liver problems and healthy volunteers
This study tests a new medicine called Y-3 in people with mild to moderate liver problems and in healthy volunteers to see how the liver affects the medicine. Participation helps researchers understand the right dose for people with liver issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 70 years old
- Weigh at least 50 kg for men or 45 kg for women, with a BMI between 18 and 30
- Have a minimum kidney function level measured by a blood test
- Either have stable mild to moderate liver impairment (Child-Pugh A or B) or be a healthy volunteer with normal liver function
- Not have taken certain medications or had recent surgeries, blood donations, or vaccinations as outlined in the full criteria
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 1 study tests a new medicine called YD0293 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This trial tests how the drug YN001 moves through the body in healthy volunteers. It helps doctors understand the right dose and safety before testing in people with a condition.
This study tests a new injectable medication to see if it is safe and how the body processes it. It is looking for healthy adults to participate and will monitor for side effects and study how the drug works.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This study tests how food affects the way a new medicine (Y-4 tablet) is processed in the body. It is looking for healthy volunteers to take a single dose of the study drug and have their blood levels checked over time.
This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.
Hear when a new Pharmacokinetic Differences trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.